C urrent guidelines from organizations such as the American Society of Clinical Oncology, the US Preventive Services Task Force, and the National Comprehensive Cancer Network for breast cancer risk reduction therapy emphasize that women at increased risk should be counseled regarding the harms and benefits of selective estrogen receptor modulators (SERMs). New research now suggests that health care providers (HCPs) must not only present the necessary medical information but, equally as important, should communicate with patients regarding their beliefs and experiences.

中文翻译：

---

降低乳腺癌风险的决策

美国临床肿瘤学会、美国预防服务工作组和国家综合癌症网络等组织的当前指南强调，应就选择性雌激素的危害和益处向风险增加的女性提供咨询受体调节剂 (SERM)。现在的新研究表明，医疗保健提供者 (HCP) 不仅必须提供必要的医疗信息，而且同样重要的是，还应该与患者就他们的信仰和经历进行交流。